Skip to main content

Table 6 Intra-laboratory reproducibility and inter-laboratory agreement of the CLART4S assay using ThinPrep screening samples

From: Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

Assessment and site HPV status Stockholm Laboratory Result 1 Total Kappa Lower bound
Hr-HPV positive Hr-HPV negative
Intra-laboratory Reproducibility
Stockholm laboratory result 2 Hr-HPV positive 56 4 60 0.70 0.90
Hr-HPV negative 34 397 431
Total 90 401 491
Inter-laboratory Agreement
Edinburgh Laboratory result Hr-HPV positive 73 10 83 0.81 0.93
Hr-HPV negative 17 395 412
Total 90 405 495